Table 4 Evaluation of clinical sensitivity and specificity with the mix of known positive and negative clinical samples.

From: Evaluation of mobile real-time polymerase chain reaction tests for the detection of severe acute respiratory syndrome coronavirus 2

(A)

 

Clinical result

Positive

Negative

Biomeme SARS-CoV-2 test result

Positive

48

0

Negative

1*

41

(B)

 

Clinical result

Positive

Negative

Precision Biomonitoring TripleLock SARS-CoV-2 test result

Positive

63

0

Negative

0

64

  1. Following the evaluation of the clinical performance of the two assays using known positive and negative clinical samples, the clinical sensitivity and specificity of the Biomeme (A) and Precision Biomonitoring TripleLock (B) SARS-CoV-2 assays were calculated.
Back to article page